Volume 25, Number 4—April 2019
Dispatch
Seroprevalence of Zika and Dengue Virus Antibodies among Migrant Workers, Taiwan, 2017
Table 1
Serostatus |
No. (%) workers |
|||||
Zika virus IgG+ |
Zika virus IgG– |
Total |
||||
Zika virus IgM+ |
Zika virus IgM– |
Zika virus IgM+ |
Zika virus IgM– |
|||
DENV IgG+ | ||||||
DENV IgM+ | 0 | 3 (0.5) | 0 | 0 | 3 (0.5) | |
DENV IgM– |
11 (1.8) |
213 (35.5) |
6 (1.0) |
251 (41.8) |
481 (80.2) |
|
DENV IgG– | ||||||
DENV IgM+ | 0 | 0 | 0 | 0 | 0 | |
DENV IgM– |
0 |
6 (1.0) |
1 (0.2) |
109 (18.2) |
116 (19.3) |
|
Total | 11 (1.8) | 222 (37.0) | 7 (1.2) | 360 (60.0) | 600 (100) |
*DENV, dengue virus; +, positive; –, negative.
Page created: March 18, 2019
Page updated: March 18, 2019
Page reviewed: March 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.